Management and Board


Tomas J. Svoboda BSc, MBA

CEO, Vorstand

In his 28 years in the life science industry, Mr Svoboda has worked in leading medical device, in-vitro diagnostic, and drug delivery/combination product companies, such as Serono, Haemonetics and Boston Scientific. Since 2000, he has been involved in various start-ups, as CEO and other senior management positions.


General Manager TEP Business Unit and Head of RA&QA

Over 20 years of experience in academic and industrial environments. Top management positions (e.g. Director manufacturing & Business Development, CSO) at Genes-x, Stemedica International, CHUV, MMV, EPFL. Dr. Nisato holds a Master in Pharmacology from the University Paris V, a Ph.D. in Biology from the University of Geneva and an MBA from HEC & École Polytechnique Fédérale de Lausanne (EPFL) and McCombs School of Business, Texas, USA.


Head of Sales & Marketing

Over 25 years of experience in the Pharmaceutical Industry including a position as Managing Director (Member of the Executive Committee) in the provision of pharmaceutical services. Diploma in Marketing and Sales at the Faculty of Pharmacy.

Team members

Marianne Sengupta

Office Manager

Over 15 years of experience in the area of Company & Fiduciary Administration, Client relations, Compliance within Private banking, Trust & Wealth Management. Since 2012 active in Office Management and Business support.



Over 5 years of experience working in the Pharmaceutical and Medical Devices Industry in areas such as Regulatory Affairs, Marketing and Sales.

Maria Widowski

Jurist, Investor relations

Over 5 years of experience in the business domain of criminal law and stock corporation law. Graduated from the University of Potsdam and currently preparing the 2nd State Exam at the Court of Berlin.

Board of directors

Torsten Cejka (Chairman)

Mr. Torsten Cejka owns his own legal practice in Germany and also serves on the board of Accentro Real Estate AG. He previously was on the Management and Supervisory Boards for Estavis AG. From 2000 to 2009, he served as a lawyer and in-house counsel to a major medium-sized German corporate group, including senior management responsibilities.

Abigael de Buys Roessingh

During last nine years providing analytical, strategic and economic expertise to help manage Charities and Foundations of which one is active in medical research.
Currently presiding over two non-profit organizations and on the executive board of another company.


CEO and Executive Director of Prima BioMed Ltd. and held various Executive or Supervisory Board positions in the past.